IoM Report On Postmarketing Study Ethics Could Drive Broad Overhaul Of Informed Consent
Executive Summary
An Institute of Medicine report on ethical and scientific issues in drug safety studies could lead to a broad restructuring of informed consent documents in postmarketing clinical trials